Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
50 studies found for:    " June 02, 2010":" July 02, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Male Involvement in Antenatal Care and the Prevention Programme of Mother-to-child Transmission of HIV in Uganda
Condition: HIV Infection
Interventions: Behavioral: Invitation letter for male spouse;   Behavioral: Information letter
2 Unknown  Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults
Condition: HIV Infection
Intervention: Biological: Adjuvanted vaccine against H1N1 influenza virus (GSK)
3 Unknown  Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border
Condition: HIV Positive
Intervention:
4 Completed Pharmacokinetics of Low Dose Raltegravir
Condition: HIV Infections
Intervention: Drug: raltegravir
5 Unknown  Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIV
Condition: HIV Infections
Intervention: Behavioral: cell phone sms text messaging
6 Completed RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice
Condition: HIV Positive
Intervention:
7 Completed Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies
Condition: HIV Infection
Interventions: Behavioral: Linkage-to-Care Component: Financial Incentive (FI);   Behavioral: Linkage-to-Care Component: Standard of Care (SOC);   Behavioral: Viral Suppression Component: FI;   Behavioral: Viral Suppression Component: SOC;   Behavioral: Prevention for Positives Component: Counseling and SOC;   Behavioral: Prevention for Positives Component: SOC
8 Completed
Has Results
Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects
Condition: HIV Infections
Interventions: Biological: TUTI-16 (0.2mg);   Biological: TUTI-16 (1.0 mg)
9 Completed Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)
Condition: HIV Infections
Intervention: Drug: ATV/r
10 Completed
Has Results
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
Conditions: HIV Seroconversion;   Stimulant Abuse
Intervention: Drug: Truvada
11 Completed A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring
Condition: HIV Infections
Interventions: Drug: dapivirine;   Drug: placebo
12 Completed Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
Condition: HIV Infections
Intervention:
13 Completed Tenofovir Gel in Pregnancy and Lactation
Condition: HIV Infections
Interventions: Drug: Tenofovir 1% gel;   Other: Placebo gel
14 Completed Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda
Condition: HIV-infection/Aids
Intervention:
15 Completed A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: The PrePex a novel device for adult male circumcision
16 Completed
Has Results
Treatment Options for Protease Inhibitor-exposed Children
Conditions: HIV/AIDS;   HIV Infections
Interventions: Drug: Efavirenz (EFV);   Drug: Lopinavir/ritonavir (LPV/r);   Drug: Stavudine (D4T);   Drug: Abacavir (ABC)
17 Completed Metabolic and Psychological Changes Associated With Menopause Among Women With HIV
Conditions: HIV Infections;   Menopause
Intervention:
18 Completed
Has Results
Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: MVA85A/AERAS-485;   Biological: Placebo
19 Active, not recruiting Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation
Conditions: Renal Function;   HIV Infection
Intervention: Other: Tc99mDTPA renal clearance
20 Completed Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: LPV/r

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.